Piper Sandler Reiterates Overweight Rating on OPKO Health
Piper Sandler reiterated its Overweight rating and $4 price target on OPKO Health. The target implies 148.4% upside from the Oct. 15 close of $1.61.
Piper Sandler reiterated its Overweight rating and $4 price target on OPKO Health. The target implies 148.4% upside from the Oct. 15 close of $1.61.